4/A: Geron Corp Director Robert J. Spiegel Corrects Form 4 Filing, Reports Acquisition of Shares
SEC Filing (Form 4/A)
Robert J. Spiegel, a director at Geron Corp, amended a previous Form 4 filing to correctly report the acquisition of shares in lieu of cash compensation.
Summary
- Robert J. Spiegel, a director at Geron Corporation, filed an amended Form 4 with the SEC.
- The amendment corrects an error in the original filing from June 28, 2024, which incorrectly reported the issuance of shares as a disposition instead of an acquisition.
- The corrected filing shows that Spiegel acquired 2,462 shares of Geron's common stock on March 29, 2024, at a price of $3.30 per share, and 1,916 shares on June 28, 2024, at a price of $4.24 per share.
- These shares were issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees.
- Following these transactions, Spiegel beneficially owns 168,418 shares of Geron's common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The correction of the form is a good sign of transparency, but the initial error is a minor concern. The director's acquisition of shares in lieu of cash compensation can be seen as a positive sign of alignment with shareholder interests.
Positives
- The corrected filing provides accurate information about the director's share ownership.
- The acquisition of shares demonstrates the director's continued investment in the company.
Negatives
- The need for an amendment indicates an initial error in reporting, which could raise concerns about internal controls.
Risks
- While the amendment corrects a previous error, repeated inaccuracies in filings could erode investor confidence.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency and compliance with SEC regulations.
Comparison to Industry Standards
- Form 4 filings are a standard requirement for directors and officers of publicly traded companies in the United States, as mandated by the Securities and Exchange Commission (SEC).
- Similar filings are required of insiders at companies like Gilead Sciences (GILD) and Amgen (AMGN) when they buy or sell shares of their respective companies.
- The level of detail required in these filings, including the number of shares, transaction dates, and prices, is consistent across all companies and aims to provide transparency to investors.
Related Party Transactions
- The issuance of shares to Robert J. Spiegel in lieu of cash compensation for board and committee fees constitutes a related party transaction.
Stakeholder Impact
- Shareholders benefit from the increased transparency provided by the corrected filing.
- The issuance of shares in lieu of cash compensation may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/29/2024 | Acquisition of 2,462 shares at $3.30 per share. |
| 06/28/2024 | Original Form 4 filing with incorrect information. |
| 06/28/2024 | Acquisition of 1,916 shares at $4.24 per share. |
| 04/02/2025 | Date of amended filing. |
Keywords
Form 4, Geron Corp, Director, Share Acquisition, Amendment, Beneficial Ownership, Robert J. Spiegel, GERN
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.